ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
41.05
0.39%
US Tech 100
20,626.00
0.07%
S&P 500
6,043.76
-0.06%
US Dollar vs CAD
1.40501
0.04%
Bitcoin
95,415.98
-0.47%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Maat Pharma SA (MAAT) Share Price

Maat Pharma SA

Maat Pharma SA (MAAT)

Monash Absolute Active Trust
7.88
0.00
(0.00%)
Closed December 03 10:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
7.88
Bid
7.86
Ask
7.90
Volume
1,080
7.88 Day's Range 7.90
6.30 52 Week Range 9.90
Market Cap
91.536M
Previous Close
7.88
Open
7.90
Last Trade
21
@
7.88
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
2,147
Shares Outstanding
11,616,199
Dividend Yield
-
PE Ratio
-4.64
Earnings Per Share (EPS)
-1.7
Revenue
2.23M
Net Profit
-19.72M

About Maat Pharma SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.maatpharma.com
Headquarters
Lyon, Rhone, Fra
Founded
-
Maat Pharma SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker MAAT. The last closing price for Maat Pharma was 7.88 €. Over the last year, Maat Pharma shares have traded in a share price range of 6.30 € to 9.90 €.

Maat Pharma currently has 11,616,199 shares outstanding. The market capitalization of Maat Pharma is 91.54 € million. Maat Pharma has a price to earnings ratio (PE ratio) of -4.64.

Ask ADVFN Intelligence (AI)

MAAT Latest News

More News

MaaT Pharma annonce des résultats positifs de Phase 1b, avec l’atteinte du critère principal pour l’évaluation de MaaT033 dans la Sclérose Latérale Amyotrophique (SLA)

MaaT033, administré sur une période de 2 mois, a confirmé un bon profil de sécurité et une bonne tolérance chez les patients atteints de la SLA. Les autres critères d'évaluation de l'étude...

November 26 2024
Business Wire

MaaT Pharma to Present Updates from Early Access Program at the 2024 ASH Annual Meeting Demonstrating Prolonged Long-Term Survival in Patients Receiving MaaT013 in aGvHD

Efficacy, safety, and long-term follow-up data from 154 patients in the EAP in Europe further reinforce the excellent clinical profile of MaaT013 in GI-aGvHD. MaaT013 is a safe and effective...

November 07 2024
Business Wire

MaaT Pharma Provides Third Quarter 2024 Business and Financial Results and Announces Management Changes

Completion of enrollment in the European Phase 3 clinical trial ARES designed to evaluate efficacy and safety of MaaT013 in the treatment of acute Graft-versus-Host Disease; topline results...

November 05 2024
Business Wire

MaaT Pharma annonce la fin du recrutement de son essai de Phase 3 ARES pour MaaT013 dans le traitement de la maladie aiguë du greffon contre l'hôte

Dernier patient traité dans l'essai clinique de Phase 3 ARES de MaaT Pharma Publication des premiers résultats désormais attendue en janvier 2025 Avis positif du DSMB pour l'essai de Phase 3...

October 15 2024
Business Wire

MaaT Pharma publie ses résultats semestriels 2024 et réalise un point sur ses activités

Données positives d'efficacité et de sécurité pour MaaT013 dans l'aGvH issues du programme d'accès compassionnel présentées lors du congrès annuel 2024 de l’EBMT avec un GI-ORR de 63% à J28, une...

September 19 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.121.546391752587.768.17.7629517.89769992DE
40.445.913978494627.448.47.3431667.90154585DE
120.547.356948228887.348.46.821477.62806025DE
26-0.12-1.588.46.5215457.5744025DE
520.7810.9859154937.19.96.316867.80422602DE
156-5.17-39.616858237513.0513.554.512178.59039959DE
260-5.62-41.629629629613.514.44.513689.24530605DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ALVETEGEIRO Pharma
0.124 €
(58.97%)
481.8k
ALDVAlliance Developpement Capital Siic
0.074 €
(32.14%)
6k
MLSRPSpeed Rabbit Pizza
8.20 €
(30.16%)
19
MLSEQSequa Petroleum NV
0.011 €
(29.41%)
12k
MLCOTCoretech 5
0.01 €
(-41.18%)
200
ATOAtos SE
0.495 €
(-32.65%)
17.92M
AFMEAffluent Medical
1.20 €
(-21.05%)
21.92k
ALBIOBiosynex
2.095 €
(-18.32%)
26.9k
TRACTTeract SA
1.03 €
(-15.23%)
76.91k
BCPBanco Comercial Portugues SA
0.4457 €
(2.20%)
44.64M
ALNEVNeovacs
0.0003 €
(0.00%)
33.59M
ATOAtos SE
0.495 €
(-32.65%)
17.92M
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ORAOrange.
9.706 €
(-2.99%)
9.65M

Discussion

View Full Feed
GrantHorvat1 GrantHorvat1 5 minutes ago
Thinking we are very very close to Gvsi ascending to new heights for 2025. In a matter of 3 weeks the 4th Q of 2024 and the 8th Q of filed Financials will be complete and George can finally put his plan into motion here. I don't think people realize how close we are to pennyland.
GVSI
mascale mascale 5 minutes ago
I can acknowledge that Senator-Elect Schiff can see a major contribution of Southern California culture to world civilizations--a paid parking lot--across the street--from Burbank City Hall. My grandfather's building is due South--Beautiful Downtown Burbank, 1920. Grandpa had been friends with Mul
HIRU
Sammy 967 Sammy 967 5 minutes ago
One thing is stopping me from purchasing the shares is uncertainty about bringing the share price above the dollar to avoid delisting. I have a feeling that they will reverse split soon. I don't see any other solution for that. Hope they have some plan. 
AMRN
don estaban don estaban 5 minutes ago
I was just going to write you and see if that was you do you think those large blocks are real?
MVNT
capgain capgain 6 minutes ago
It was very sad hearing about him, he was a long time Ihubber for sure.
diamondguru-one diamondguru-one 6 minutes ago
I just sold all my dead beats and backed up the truck on this play.....NASA DEAL along is $4.00 easy
KULR
Mark Mark 7 minutes ago
$APDN .17, give us .20+ please
APDN
ignatiusrielly35 ignatiusrielly35 7 minutes ago
I agree with you. I'd go with Amazon only for an established drug that the pharma is already marketing. I would not go with Amazon for a new drug, with a novel MOA, that the pharma (Anavex) has no ability to market on its own. 
AVXL
SPARK SPARK 7 minutes ago
lol~
Risk vs Reward Risk vs Reward 7 minutes ago
I'm very big on Tesla too but do you have some new source to add the the conjecture we already think might happen ? Just asking... cause damn that with be sweet 
KULR
dcwisc dcwisc 7 minutes ago
://www.youtube.com/watch?v=X4F2XLHJP6A
NBRI
jimr1717 jimr1717 7 minutes ago
MOTORCYCLIST DIES IN CRASH ON 91ST STREET IN TULSA
Tulsa Police are investigating a fatal motorcycle crash early Tuesday morning.
Tuesday, December 3rd 2024, 4:38 am
By: News On 6

https://www.news9.com/story/674edf4c4e8bb8f412af5197/motorcyclist-dies-in-crash-on-9
TSLA
trading.jeff trading.jeff 7 minutes ago
I'm long and bullish, as you know, but this is a fluff article. Where are the fins???? Where is the OS reduction????

$APRU
APRU
Scope08 Scope08 8 minutes ago
This is a good example....a "sales report" was posted today. Seemingly good news.
I discounted it until I see further confirmation, didn't rah rah comment on it, and I moved on.

TP however, seems to be unnerved by it's posting....because it doesn't fit in with his narrative.
LWLG
capgain capgain 8 minutes ago
It was a crazy one, hard on the blood pressure lol
konshe konshe 8 minutes ago
Why are you here? If you don't like the company, just leave, no need waste your time to bashing stock.
CBDL
Stinger2014 Stinger2014 8 minutes ago
So now you’re going down?? lol 😂
CGAC
3331 3331 8 minutes ago
BIEL #3 BREAKOUT BOARD, GOLDEN CROSS BLUE SKY BREAKOUT, GONNA RUN LIKE 2021!
Risk vs Reward Risk vs Reward 9 minutes ago
Everybody's getting in position for the run of a lifetime 
KULR
coolhandluke88 coolhandluke88 9 minutes ago
I just came back to see if the millions of shares I had from flipping this thing years ago would ever be worth anything. Answer appears to be hell no. Only people here or a bunch of idiots. No need to come back. I will go back to the big boards were I flipped ATIP for $15000 this am. 1.80 to 2.4
ATIP
al44 al44 9 minutes ago
When the light shines-

https://media.gettr.com/group8/getter/2024/12/03/18/f9012a52-cbf4-ae7b-22a7-e4b60995db17/719ff586948a554ed229264ce4a2556c_768x0.png
silvr_surfr silvr_surfr 9 minutes ago
Maybe we will get some news ahead of tomorrow's Piper Sandler Healthcare Conference. Probably not.
ANIP
linkvest linkvest 9 minutes ago
They want the 9s. They are trying to walk it down to grab up the 9s that might fall.
RDAR
Peace1965 Peace1965 9 minutes ago
X is the best place to post.. Lakota wouldn’t show his face there..
INQD

Your Recent History

EU
MAAT
Maat Pharma
TG
HEN3
Henkel AG & Co KGAA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved